Free Trial
NYSE:NHI

National Health Investors (NHI) Stock Price, News & Analysis

National Health Investors logo
$73.48 +1.02 (+1.40%)
Closing price 05/27/2025 03:59 PM Eastern
Extended Trading
$73.54 +0.05 (+0.07%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About National Health Investors Stock (NYSE:NHI)

Key Stats

Today's Range
$72.46
$73.85
50-Day Range
$68.60
$76.78
52-Week Range
$63.91
$86.13
Volume
267,132 shs
Average Volume
227,594 shs
Market Capitalization
$3.43 billion
P/E Ratio
25.25
Dividend Yield
4.90%
Price Target
$85.50
Consensus Rating
Moderate Buy

Company Overview

Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

National Health Investors Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
74th Percentile Overall Score

NHI MarketRank™: 

National Health Investors scored higher than 74% of companies evaluated by MarketBeat, and ranked 426th out of 909 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    National Health Investors has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    National Health Investors has only been the subject of 2 research reports in the past 90 days.

  • Read more about National Health Investors' stock forecast and price target.
  • Earnings Growth

    Earnings for National Health Investors are expected to grow by 5.67% in the coming year, from $4.41 to $4.66 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of National Health Investors is 25.25, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.89.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of National Health Investors is 25.25, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 22.68.

  • Price to Earnings Growth Ratio

    National Health Investors has a PEG Ratio of 4.42. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    National Health Investors has a P/B Ratio of 2.52. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about National Health Investors' valuation and earnings.
  • Percentage of Shares Shorted

    3.28% of the float of National Health Investors has been sold short.
  • Short Interest Ratio / Days to Cover

    National Health Investors has a short interest ratio ("days to cover") of 6.
  • Change versus previous month

    Short interest in National Health Investors has recently decreased by 3.95%, indicating that investor sentiment is improving.
  • Dividend Leadership

    National Health Investors is a leading dividend payer. It pays a dividend yield of 4.82%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    National Health Investors does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of National Health Investors is 114.29%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Dividend Sustainability

    Based on EPS estimates, National Health Investors will have a dividend payout ratio of 77.25% in the coming year. This indicates that National Health Investors may not be able to sustain their current dividend.

  • Read more about National Health Investors' dividend.
  • Percentage of Shares Shorted

    3.28% of the float of National Health Investors has been sold short.
  • Short Interest Ratio / Days to Cover

    National Health Investors has a short interest ratio ("days to cover") of 6.
  • Change versus previous month

    Short interest in National Health Investors has recently decreased by 3.95%, indicating that investor sentiment is improving.
  • News Sentiment

    National Health Investors has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.12 average news sentiment score of Finance companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for National Health Investors this week, compared to 5 articles on an average week.
  • MarketBeat Follows

    1 people have added National Health Investors to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, National Health Investors insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.26% of the stock of National Health Investors is held by insiders.

  • Percentage Held by Institutions

    62.51% of the stock of National Health Investors is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about National Health Investors' insider trading history.
Receive NHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Health Investors and its competitors with MarketBeat's FREE daily newsletter.

NHI Stock News Headlines

Trump’s Bitcoin Reserve is No Accident…
For the first time in history, we have a president who understands crypto's potential to bypass the banking system entirely. And Wall Street's biggest players know it. I've created a blueprint revealing how everyday investors can turn this historic shift into potentially life-changing wealth. Like the 75,000 new millionaires created in the last bull run— only this time with institutional backing.
See More Headlines

NHI Stock Analysis - Frequently Asked Questions

National Health Investors' stock was trading at $69.30 on January 1st, 2025. Since then, NHI shares have increased by 6.0% and is now trading at $73.4850.
View the best growth stocks for 2025 here
.

National Health Investors, Inc. (NYSE:NHI) posted its earnings results on Monday, May, 5th. The real estate investment trust reported $1.15 EPS for the quarter, beating the consensus estimate of $1.13 by $0.02. National Health Investors's quarterly revenue was up 9.6% on a year-over-year basis.
Read the conference call transcript
.

National Health Investors' top institutional investors include Vanguard Group Inc. (13.61%), Principal Financial Group Inc. (3.49%), Charles Schwab Investment Management Inc. (1.65%) and Northern Trust Corp (1.32%). Insiders that own company stock include Robert G Adams, Charlotte A Swafford and James R Jobe.
View institutional ownership trends
.

Shares of NHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that National Health Investors investors own include NVIDIA (NVDA), Meta Platforms (META), JPMorgan Chase & Co. (JPM), Intel (INTC), Tesla (TSLA), Advanced Micro Devices (AMD) and Exxon Mobil (XOM).

Company Calendar

Record date for 5/2 Dividend
3/31/2025
Ex-Dividend for 5/2 Dividend
3/31/2025
Dividend Payable
5/02/2025
Last Earnings
5/05/2025
Today
5/28/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Finance
Industry
Real estate investment trusts
Sub-Industry
Specialized REITs
Current Symbol
NYSE:NHI
Employees
20
Year Founded
1991

Price Target and Rating

Average Stock Price Target
$85.50
High Stock Price Target
$92.00
Low Stock Price Target
$76.00
Potential Upside/Downside
+16.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
25.25
Forward P/E Ratio
16.66
P/E Growth
4.42
Net Income
$135.65 million
Pretax Margin
38.18%

Debt

Sales & Book Value

Annual Sales
$342.96 million
Cash Flow
$5.15 per share
Price / Cash Flow
14.26
Book Value
$29.13 per share
Price / Book
2.52

Miscellaneous

Free Float
42,124,000
Market Cap
$3.43 billion
Optionable
Optionable
Beta
0.78

Social Links

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NYSE:NHI) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners